speb/financial-data huggingface dataset:
DOCS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 12397000.00
DOCS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 12397000.00
DOCS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 30405000.00
DOCS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
DOCS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: -280716000.00
DOCS income_statement (annual, 2024-03-31) — Net Income: 147582000.00
DOCS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 147582000.00
DOCS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 147582000.00
DOCS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 147582000.00
DOCS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 147582000.00
DOCS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 147582000.00
DOCS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 147582000.00
DOCS cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: -5654000.00
DOCS income_statement (annual, 2024-03-31) — Net Interest Income: 21664000.00
DOCS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 36987000.00
DOCS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 21664000.00
DOCS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -12146000.00
DOCS balance_sheet (annual, 2024-03-31) — Net PPE: 24650000.00
DOCS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -147000.00
DOCS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 806140000.00
DOCS balance_sheet (annual, 2024-03-31) — Non Current Deferred Assets: 45068000.00
DOCS balance_sheet (annual, 2024-03-31) — Non Current Deferred Liabilities: 211000.00
DOCS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 211000.00
DOCS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 45068000.00
DOCS income_statement (annual, 2024-03-31) — Normalized EBITDA: 190417000.00
DOCS income_statement (annual, 2024-03-31) — Normalized Income: 154226305.76
DOCS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 184096000.00
DOCS cash_flow (annual, 2024-03-31) — Operating Gains Losses: 402000.00
DOCS income_statement (annual, 2024-03-31) — Operating Income: 171814000.00
DOCS income_statement (annual, 2024-03-31) — Operating Revenue: 450071000.00
DOCS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 186561649.00
DOCS balance_sheet (annual, 2024-03-31) — Other Current Assets: 48709000.00
DOCS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 14277000.00
DOCS balance_sheet (annual, 2024-03-31) — Other Equity Adjustments: -2664000.00
DOCS income_statement (annual, 2024-03-31) — Other Gand A: 37827000.00
DOCS income_statement (annual, 2024-03-31) — Other Income Expense: -8276000.00
DOCS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 27317000.00
DOCS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 13528000.00
DOCS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 1458000.00
DOCS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 18119000.00
DOCS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 62000.00
DOCS balance_sheet (annual, 2024-03-31) — Other Properties: 12332000.00
DOCS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 666115000.00
DOCS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
DOCS balance_sheet (annual, 2024-03-31) — Payables: 16271000.00
DOCS balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 31183000.00
DOCS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 496000.00
DOCS balance_sheet (annual, 2024-03-31) — Preferred Stock: 0.00
DOCS income_statement (annual, 2024-03-31) — Pretax Income: 185202000.00
DOCS cash_flow (annual, 2024-03-31) — Proceeds From Stock Option Exercised: 16338000.00
DOCS balance_sheet (annual, 2024-03-31) — Properties: 0.00
DOCS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
DOCS cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: -5654000.00
DOCS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -472867000.00
DOCS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -147000.00
DOCS balance_sheet (annual, 2024-03-31) — Receivables: 101332000.00
DOCS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 50669000.00
DOCS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 10265000.00
DOCS cash_flow (annual, 2024-03-31) — Repurchase Of Capital Stock: -280716000.00
DOCS income_statement (annual, 2024-03-31) — Research And Development: 81983000.00
DOCS income_statement (annual, 2024-03-31) — Restructuring And Mergern Acquisition: 7936000.00
DOCS balance_sheet (annual, 2024-03-31) — Retained Earnings: 79989000.00
DOCS cash_flow (annual, 2024-03-31) — Sale Of Investment: 509854000.00
DOCS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 133129000.00
DOCS income_statement (annual, 2024-03-31) — Selling General And Administration: 170956000.00
DOCS balance_sheet (annual, 2024-03-31) — Share Issued: 186561649.00
DOCS income_statement (annual, 2024-03-31) — Special Income Charges: -7936000.00
DOCS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 51076000.00
DOCS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 901397000.00
DOCS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 806140000.00
DOCS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -1693694.24
DOCS income_statement (annual, 2024-03-31) — Tax Provision: 37620000.00
DOCS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.20
DOCS balance_sheet (annual, 2024-03-31) — Total Assets: 1079374000.00
DOCS balance_sheet (annual, 2024-03-31) — Total Capitalization: 901397000.00
DOCS balance_sheet (annual, 2024-03-31) — Total Debt: 14546000.00
DOCS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 901397000.00
DOCS income_statement (annual, 2024-03-31) — Total Expenses: 303608000.00
DOCS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 177977000.00
DOCS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 166433000.00
DOCS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 30727000.00
DOCS income_statement (annual, 2024-03-31) — Total Operating Income As Reported: 163878000.00
DOCS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 14018000.00
DOCS income_statement (annual, 2024-03-31) — Total Unusual Items: -8338000.00
DOCS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -8338000.00
DOCS balance_sheet (annual, 2024-03-31) — Working Capital: 765691000.00
DOCS income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: 31000.00
DOCS balance_sheet (quarterly, 2024-09-30) — Income Tax Payable: 5353000.00
DOCS cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: 0.00
DOCS cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: 0.00
DOCS income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 2304000.00
DOCS cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
DOCS cash_flow (quarterly, 2024-12-31) — Deferred Income Tax: 1992000.00
DOCS cash_flow (quarterly, 2024-12-31) — Deferred Tax: 1992000.00
DOCS income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 59000.00
DOCS cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
DOCS cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 0.00
DOCS cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
DOCS cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 0.00
DOCS income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
DOCS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
DOCS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 59000.00
DOCS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 59000.00
DOCS income_statement (quarterly, 2024-12-31) — Write Off: 0.00
DOCS income_statement (annual, 2025-03-31) — +Operating Expense: 284421000.00
DOCS income_statement (quarterly, 2025-03-31) — +Operating Expense: 75141000.00
DOCS income_statement (annual, 2025-03-31) — +Total Revenue: 570399000.00
DOCS income_statement (quarterly, 2025-03-31) — +Total Revenue: 138288000.00
DOCS balance_sheet (annual, 2025-03-31) — Accounts Payable: 1356000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1356000.00
DOCS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 128354000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 128354000.00
DOCS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -24947000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -24947000.00
DOCS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 894225000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 894225000.00
DOCS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1937000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1937000.00
DOCS cash_flow (annual, 2025-03-31) — Amortization Of Securities: -11655000.00
DOCS cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -2919000.00
DOCS cash_flow (annual, 2025-03-31) — Asset Impairment Charge: 2304000.00
DOCS cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
DOCS income_statement (annual, 2025-03-31) — Basic Average Shares: 186841000.00
DOCS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 188362000.00
DOCS income_statement (annual, 2025-03-31) — Basic EPS: 1.19
DOCS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.33
DOCS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 96785000.00
DOCS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 165270000.00
DOCS cash_flow (annual, 2025-03-31) — Capital Expenditure: -6525000.00
DOCS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1507000.00
DOCS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 12396000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 12396000.00
DOCS balance_sheet (annual, 2025-03-31) — Capital Stock: 189000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 189000.00
DOCS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 209614000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 209614000.00
DOCS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 915664000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 915664000.00
DOCS cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: -131138000.00
DOCS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -29670000.00
DOCS cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: -29298000.00
DOCS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -24473000.00
DOCS cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Operating Activities: 273265000.00
DOCS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 98487000.00
DOCS cash_flow (annual, 2025-03-31) — Change In Account Payable: -663000.00
DOCS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -4535000.00
DOCS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -2149000.00
DOCS cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -550000.00
DOCS cash_flow (annual, 2025-03-31) — Change In Other Working Capital: 3159000.00
DOCS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 42313000.00
DOCS cash_flow (annual, 2025-03-31) — Change In Payable: -663000.00
DOCS cash_flow (quarterly, 2025-03-31) — Change In Payable: -4535000.00
DOCS cash_flow (annual, 2025-03-31) — Change In Payables And Accrued Expense: -663000.00
DOCS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -4535000.00
DOCS cash_flow (annual, 2025-03-31) — Change In Prepaid Assets: 2762000.00
DOCS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -18489000.00
DOCS cash_flow (annual, 2025-03-31) — Change In Receivables: -27206000.00
DOCS cash_flow (quarterly, 2025-03-31) — Change In Receivables: 9258000.00
DOCS cash_flow (annual, 2025-03-31) — Change In Working Capital: -24097000.00
DOCS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 27997000.00
DOCS cash_flow (annual, 2025-03-31) — Changes In Account Receivables: -27206000.00
DOCS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 9258000.00
DOCS cash_flow (annual, 2025-03-31) — Changes In Cash: 112829000.00
DOCS cash_flow (quarterly, 2025-03-31) — Changes In Cash: 44344000.00
DOCS balance_sheet (annual, 2025-03-31) — Common Stock: 189000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Common Stock: 189000.00
DOCS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 1082625000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1082625000.00
DOCS cash_flow (annual, 2025-03-31) — Common Stock Payments: -120293000.00
DOCS cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -26788000.00
DOCS income_statement (annual, 2025-03-31) — Cost Of Revenue: 55874000.00
DOCS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 14467000.00
DOCS balance_sheet (annual, 2025-03-31) — Current Accrued Expenses: 24986000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 24986000.00
DOCS balance_sheet (annual, 2025-03-31) — Current Assets: 1088620000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Current Assets: 1088620000.00
DOCS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 2211000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 2211000.00
DOCS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 2211000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2211000.00
DOCS balance_sheet (annual, 2025-03-31) — Current Deferred Liabilities: 114285000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 114285000.00
DOCS balance_sheet (annual, 2025-03-31) — Current Deferred Revenue: 114285000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 114285000.00
DOCS balance_sheet (annual, 2025-03-31) — Current Liabilities: 156257000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 156257000.00
DOCS cash_flow (annual, 2025-03-31) — Deferred Income Tax: -11592000.00
DOCS cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -13788000.00
DOCS cash_flow (annual, 2025-03-31) — Deferred Tax: -11592000.00
DOCS cash_flow (quarterly, 2025-03-31) — Deferred Tax: -13788000.00
DOCS cash_flow (annual, 2025-03-31) — Depreciation Amortization Depletion: 10659000.00
DOCS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2829000.00
DOCS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 10659000.00
DOCS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2829000.00
DOCS income_statement (annual, 2025-03-31) — Diluted Average Shares: 201208000.00
DOCS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 202987000.00
DOCS income_statement (annual, 2025-03-31) — Diluted EPS: 1.11
DOCS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.31
DOCS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 223185000.00
DOCS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 62458000.00
DOCS income_statement (annual, 2025-03-31) — EBIT: 230104000.00
DOCS income_statement (quarterly, 2025-03-31) — EBIT: 48680000.00
DOCS income_statement (annual, 2025-03-31) — EBITDA: 240763000.00
DOCS income_statement (quarterly, 2025-03-31) — EBITDA: 51509000.00
DOCS cash_flow (annual, 2025-03-31) — End Cash Position: 209614000.00
DOCS cash_flow (quarterly, 2025-03-31) — End Cash Position: 209614000.00
DOCS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -131138000.00
DOCS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -29670000.00
DOCS cash_flow (annual, 2025-03-31) — Free Cash Flow: 266740000.00
DOCS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 96980000.00
DOCS income_statement (annual, 2025-03-31) — Gain On Sale Of Security: 169000.00
DOCS income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 79000.00
DOCS balance_sheet (annual, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 1323000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 1323000.00
DOCS income_statement (annual, 2025-03-31) — General And Administrative Expense: 45670000.00
DOCS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 12727000.00
DOCS balance_sheet (annual, 2025-03-31) — Goodwill: 67940000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Goodwill: 67940000.00
DOCS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 91012000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 91012000.00
DOCS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 130291000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 130291000.00
DOCS balance_sheet (annual, 2025-03-31) — Gross PPE: 47489000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 47489000.00
DOCS income_statement (annual, 2025-03-31) — Gross Profit: 514525000.00
DOCS income_statement (quarterly, 2025-03-31) — Gross Profit: 123821000.00
DOCS cash_flow (annual, 2025-03-31) — Income Tax Paid Supplemental Data: 55654000.00
DOCS cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 19840000.00
DOCS balance_sheet (annual, 2025-03-31) — Income Tax Payable: 0.00
DOCS balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 0.00
DOCS income_statement (annual, 2025-03-31) — Interest Income: 35852000.00
DOCS income_statement (quarterly, 2025-03-31) — Interest Income: 9686000.00
DOCS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 35852000.00
DOCS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 9686000.00
DOCS balance_sheet (annual, 2025-03-31) — Invested Capital: 1082625000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1082625000.00
DOCS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -29298000.00
DOCS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -24473000.00
DOCS balance_sheet (annual, 2025-03-31) — Leases: 816000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Leases: 816000.00
DOCS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 10185000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 10185000.00
DOCS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 10185000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 10185000.00
DOCS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 37787000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 37787000.00
DOCS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
DOCS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: -120293000.00
DOCS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -26788000.00
DOCS income_statement (annual, 2025-03-31) — Net Income: 223185000.00
DOCS income_statement (quarterly, 2025-03-31) — Net Income: 62458000.00
DOCS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 223185000.00
DOCS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 62458000.00
DOCS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 223185000.00
DOCS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 62458000.00
DOCS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 223185000.00
DOCS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 62458000.00
DOCS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 223185000.00
DOCS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 62458000.00
DOCS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 223185000.00
DOCS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 62458000.00
DOCS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 223185000.00
DOCS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 62458000.00
DOCS cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -6525000.00
DOCS cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -1507000.00
DOCS income_statement (annual, 2025-03-31) — Net Interest Income: 35852000.00
DOCS income_statement (quarterly, 2025-03-31) — Net Interest Income: 9686000.00
DOCS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -22773000.00
DOCS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -22966000.00
DOCS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 35852000.00
DOCS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 9686000.00
DOCS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -34146000.00
DOCS cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -10856000.00
DOCS balance_sheet (annual, 2025-03-31) — Net PPE: 22542000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Net PPE: 22542000.00
DOCS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: 0.00
DOCS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
DOCS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 991613000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 991613000.00
DOCS balance_sheet (annual, 2025-03-31) — Non Current Deferred Assets: 60014000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 60014000.00
DOCS balance_sheet (annual, 2025-03-31) — Non Current Deferred Liabilities: 280000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 280000.00
DOCS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 280000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 280000.00
DOCS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 60014000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 60014000.00
DOCS income_statement (annual, 2025-03-31) — Normalized EBITDA: 242898000.00
DOCS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 51430000.00
DOCS income_statement (annual, 2025-03-31) — Normalized Income: 224992841.35
DOCS income_statement (quarterly, 2025-03-31) — Normalized Income: 62395590.00
DOCS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 273265000.00
DOCS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 98487000.00
DOCS income_statement (annual, 2025-03-31) — Operating Income: 230104000.00
DOCS income_statement (quarterly, 2025-03-31) — Operating Income: 48680000.00
DOCS income_statement (annual, 2025-03-31) — Operating Revenue: 543770000.00
DOCS income_statement (quarterly, 2025-03-31) — Operating Revenue: 131902000.00
DOCS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 188875301.00
DOCS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 188875301.00
DOCS balance_sheet (annual, 2025-03-31) — Other Current Assets: 44602000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 44602000.00
DOCS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 11475000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 11475000.00
DOCS balance_sheet (annual, 2025-03-31) — Other Equity Adjustments: 1323000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 1323000.00
DOCS income_statement (annual, 2025-03-31) — Other Gand A: 45670000.00
DOCS income_statement (quarterly, 2025-03-31) — Other Gand A: 12727000.00
DOCS income_statement (annual, 2025-03-31) — Other Income Expense: -2382000.00
DOCS income_statement (quarterly, 2025-03-31) — Other Income Expense: 28000.00
DOCS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 23072000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 23072000.00
DOCS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 12075000.00
DOCS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 3850000.00
DOCS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 2121000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 2121000.00
DOCS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 14962000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 14962000.00
DOCS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: -247000.00
DOCS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -51000.00
DOCS balance_sheet (annual, 2025-03-31) — Other Properties: 8886000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Other Properties: 8886000.00
DOCS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 706050000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 706050000.00
DOCS balance_sheet (annual, 2025-03-31) — Payables: 2713000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Payables: 2713000.00
DOCS balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 27699000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 27699000.00
DOCS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 587000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 587000.00
DOCS balance_sheet (annual, 2025-03-31) — Preferred Stock: 0.00
DOCS balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
DOCS income_statement (annual, 2025-03-31) — Pretax Income: 263574000.00
DOCS income_statement (quarterly, 2025-03-31) — Pretax Income: 58394000.00
DOCS cash_flow (annual, 2025-03-31) — Proceeds From Stock Option Exercised: 23301000.00
DOCS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 7974000.00
DOCS balance_sheet (annual, 2025-03-31) — Properties: 0.00
DOCS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
DOCS cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
DOCS cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -6525000.00
DOCS cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -1507000.00
DOCS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -675557000.00
DOCS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -143724000.00
DOCS cash_flow (annual, 2025-03-31) — Purchase Of PPE: 0.00
DOCS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
DOCS balance_sheet (annual, 2025-03-31) — Receivables: 128354000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Receivables: 128354000.00
DOCS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 55874000.00
DOCS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 14467000.00
DOCS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 10659000.00
DOCS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2829000.00
DOCS cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: -120293000.00
DOCS cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -26788000.00
DOCS income_statement (annual, 2025-03-31) — Research And Development: 93038000.00
DOCS income_statement (quarterly, 2025-03-31) — Research And Development: 24803000.00
DOCS balance_sheet (annual, 2025-03-31) — Retained Earnings: 186888000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 186888000.00
DOCS cash_flow (annual, 2025-03-31) — Sale Of Investment: 652784000.00
DOCS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 120758000.00
DOCS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 145713000.00
DOCS income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 37611000.00
DOCS income_statement (annual, 2025-03-31) — Selling General And Administration: 191383000.00
DOCS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 50338000.00
DOCS balance_sheet (annual, 2025-03-31) — Share Issued: 188875301.00
DOCS balance_sheet (quarterly, 2025-03-31) — Share Issued: 188875301.00
DOCS income_statement (annual, 2025-03-31) — Special Income Charges: -2304000.00
DOCS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
DOCS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 72386000.00
DOCS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 18060000.00
DOCS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 1082625000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1082625000.00
DOCS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 991613000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 991613000.00
DOCS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -327158.65
DOCS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 16590.00
DOCS income_statement (annual, 2025-03-31) — Tax Provision: 40389000.00
DOCS income_statement (quarterly, 2025-03-31) — Tax Provision: -4064000.00
DOCS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.15
DOCS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
DOCS balance_sheet (annual, 2025-03-31) — Total Assets: 1264309000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Total Assets: 1264309000.00
DOCS balance_sheet (annual, 2025-03-31) — Total Capitalization: 1082625000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1082625000.00
DOCS balance_sheet (annual, 2025-03-31) — Total Debt: 12396000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Total Debt: 12396000.00
DOCS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 1082625000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1082625000.00
DOCS income_statement (annual, 2025-03-31) — Total Expenses: 340295000.00
DOCS income_statement (quarterly, 2025-03-31) — Total Expenses: 89608000.00
DOCS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 181684000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 181684000.00
DOCS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 175689000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 175689000.00
DOCS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 25427000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 25427000.00
DOCS income_statement (annual, 2025-03-31) — Total Operating Income As Reported: 227800000.00
DOCS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 48680000.00
DOCS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 1357000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 1357000.00
DOCS income_statement (annual, 2025-03-31) — Total Unusual Items: -2135000.00
DOCS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 79000.00
DOCS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -2135000.00
DOCS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 79000.00
DOCS balance_sheet (annual, 2025-03-31) — Working Capital: 932363000.00
DOCS balance_sheet (quarterly, 2025-03-31) — Working Capital: 932363000.00
DOCS income_statement (quarterly, 2025-06-30) — +Operating Expense: 75603000.00
DOCS income_statement (quarterly, 2025-06-30) — +Total Revenue: 145913000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1962000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 141663000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -26403000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 907115000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -1871000.00
DOCS cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -2488000.00
DOCS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 187984000.00
DOCS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.28
DOCS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 209614000.00
DOCS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1966000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 11841000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 187000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 137261000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 840973000.00
DOCS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -137133000.00
DOCS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 2679000.00
DOCS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 62101000.00
DOCS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -165000.00
DOCS cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -556000.00
DOCS cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 1008000.00
DOCS cash_flow (quarterly, 2025-06-30) — Change In Payable: -165000.00
DOCS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -165000.00
DOCS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -4234000.00
DOCS cash_flow (quarterly, 2025-06-30) — Change In Receivables: -13381000.00
DOCS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -17328000.00
DOCS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -13381000.00
DOCS cash_flow (quarterly, 2025-06-30) — Changes In Cash: -72353000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Common Stock: 187000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1025595000.00
DOCS cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -122355000.00
DOCS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 15793000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 15792000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Current Assets: 1034231000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 2168000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 2168000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 117419000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 117419000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 159912000.00
DOCS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2794000.00
DOCS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2794000.00
DOCS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 201158000.00
DOCS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.27
DOCS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 53320000.00
DOCS income_statement (quarterly, 2025-06-30) — EBIT: 54517000.00
DOCS income_statement (quarterly, 2025-06-30) — EBITDA: 57311000.00
DOCS cash_flow (quarterly, 2025-06-30) — End Cash Position: 137261000.00
DOCS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -137133000.00
DOCS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 60135000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1183000.00
DOCS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 12439000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Goodwill: 67940000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 90009000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 143534000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 49114000.00
DOCS income_statement (quarterly, 2025-06-30) — Gross Profit: 130120000.00
DOCS cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 4978000.00
DOCS income_statement (quarterly, 2025-06-30) — Interest Income: 9865000.00
DOCS income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 9865000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1025595000.00
DOCS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 2679000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Leases: 816000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 9673000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 9673000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 39862000.00
DOCS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -122355000.00
DOCS income_statement (quarterly, 2025-06-30) — Net Income: 53320000.00
DOCS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 53320000.00
DOCS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 53320000.00
DOCS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 53320000.00
DOCS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 53320000.00
DOCS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 53320000.00
DOCS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 53320000.00
DOCS cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -1966000.00
DOCS income_statement (quarterly, 2025-06-30) — Net Interest Income: 9865000.00
DOCS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 4645000.00
DOCS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 9865000.00
DOCS cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -17176000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Net PPE: 22711000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 935586000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 55461000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 118000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 118000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 55461000.00
DOCS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 57311000.00
DOCS income_statement (quarterly, 2025-06-30) — Normalized Income: 53320000.00
DOCS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 62101000.00
DOCS income_statement (quarterly, 2025-06-30) — Operating Income: 54517000.00
DOCS income_statement (quarterly, 2025-06-30) — Operating Revenue: 137876000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 187452885.00
DOCS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 51595000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 10502000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1183000.00
DOCS income_statement (quarterly, 2025-06-30) — Other Gand A: 12439000.00
DOCS income_statement (quarterly, 2025-06-30) — Other Income Expense: -235000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 22069000.00
DOCS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 3938000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 2035000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 9149000.00
DOCS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -235000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Other Properties: 8436000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 703712000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Payables: 12314000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 28106000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 1717000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
DOCS income_statement (quarterly, 2025-06-30) — Pretax Income: 64147000.00
DOCS cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 2398000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
DOCS cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -1966000.00
DOCS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -139934000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Receivables: 141663000.00
DOCS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 15793000.00
DOCS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2794000.00
DOCS cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -122355000.00
DOCS income_statement (quarterly, 2025-06-30) — Research And Development: 26799000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 117110000.00
DOCS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 144579000.00
DOCS income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 36365000.00
DOCS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 48804000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Share Issued: 187452885.00
DOCS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 21865000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1025595000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 935586000.00
DOCS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
DOCS income_statement (quarterly, 2025-06-30) — Tax Provision: 10827000.00
DOCS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.17
DOCS balance_sheet (quarterly, 2025-06-30) — Total Assets: 1204447000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1025595000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Total Debt: 11841000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1025595000.00
DOCS income_statement (quarterly, 2025-06-30) — Total Expenses: 91396000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 178852000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 170216000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 18940000.00
DOCS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 54517000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 10352000.00
DOCS balance_sheet (quarterly, 2025-06-30) — Working Capital: 874319000.00
DOCS income_statement (quarterly, 2025-09-30) — +Operating Expense: 88419000.00
DOCS income_statement (quarterly, 2025-09-30) — +Total Revenue: 168525000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4391000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 129306000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -27782000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 936176000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -1508000.00
DOCS cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -2199000.00
DOCS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 187705000.00
DOCS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.33
DOCS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 137261000.00
DOCS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -2369000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 11269000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 188000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 169249000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 878367000.00
DOCS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -30245000.00
DOCS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -31711000.00
DOCS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 93944000.00
DOCS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -2168000.00
DOCS cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -571000.00
DOCS cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -19825000.00
DOCS cash_flow (quarterly, 2025-09-30) — Change In Payable: -2168000.00
DOCS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -2168000.00
DOCS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 7685000.00
DOCS cash_flow (quarterly, 2025-09-30) — Change In Receivables: 12396000.00
DOCS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -2483000.00
DOCS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 12396000.00
DOCS cash_flow (quarterly, 2025-09-30) — Changes In Cash: 31988000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Common Stock: 188000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1095531000.00
DOCS cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -21893000.00
DOCS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 16425000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 17226000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Current Assets: 1092200000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 2123000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2123000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 100034000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 100034000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 140270000.00
DOCS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 3469000.00
DOCS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 3469000.00
DOCS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 200745000.00
DOCS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.31
DOCS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 62059000.00
DOCS income_statement (quarterly, 2025-09-30) — EBIT: 63681000.00
DOCS income_statement (quarterly, 2025-09-30) — EBITDA: 67150000.00
DOCS cash_flow (quarterly, 2025-09-30) — End Cash Position: 169249000.00
DOCS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -30245000.00
DOCS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 91575000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 1477000.00
DOCS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 19049000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Goodwill: 84973000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 124116000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 130814000.00
DOCS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 51476000.00
DOCS income_statement (quarterly, 2025-09-30) — Gross Profit: 152100000.00
DOCS income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00